XWELL EBITDA Margin 2012-2025 | XWEL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for XWELL (XWEL) over the last 10 years. The current EBITDA margin for XWELL as of September 30, 2025 is .
| XWELL EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $0.03B | $-0.01B | -41.38% |
| 2025-06-30 | $0.03B | $-0.02B | -53.33% |
| 2025-03-31 | $0.03B | $-0.02B | -48.39% |
| 2024-12-31 | $0.03B | $-0.01B | -42.42% |
| 2024-09-30 | $0.03B | $-0.01B | -15.15% |
| 2024-06-30 | $0.03B | $-0.01B | -37.50% |
| 2024-03-31 | $0.03B | $-0.02B | -48.39% |
| 2023-12-31 | $0.03B | $-0.02B | -62.07% |
| 2023-09-30 | $0.03B | $-0.03B | -106.67% |
| 2023-06-30 | $0.03B | $-0.03B | -79.41% |
| 2023-03-31 | $0.04B | $-0.03B | -72.50% |
| 2022-12-31 | $0.06B | $-0.03B | -43.86% |
| 2022-09-30 | $0.08B | $-0.01B | -12.82% |
| 2022-06-30 | $0.09B | $0.00B | 4.26% |
| 2022-03-31 | $0.09B | $0.01B | 7.87% |
| 2021-12-31 | $0.07B | $0.01B | 10.81% |
| 2021-09-30 | $0.05B | $-0.01B | -26.67% |
| 2021-06-30 | $0.02B | $-0.03B | -150.00% |
| 2021-03-31 | $0.01B | $-0.03B | -344.44% |
| 2020-12-31 | $0.01B | $-0.03B | -400.00% |
| 2020-09-30 | $0.02B | $-0.02B | -126.32% |
| 2020-06-30 | $0.03B | $-0.02B | -46.88% |
| 2020-03-31 | $0.05B | $-0.01B | -20.00% |
| 2019-12-31 | $0.05B | $-0.01B | -16.33% |
| 2019-09-30 | $0.05B | $0.00B | -4.00% |
| 2019-06-30 | $0.05B | $-0.01B | -10.00% |
| 2019-03-31 | $0.05B | $-0.01B | -10.00% |
| 2018-12-31 | $0.05B | $-0.01B | -13.73% |
| 2018-09-30 | $0.05B | $-0.01B | -9.80% |
| 2018-06-30 | $0.05B | $-0.01B | -11.76% |
| 2018-03-31 | $0.05B | $-0.01B | -11.76% |
| 2017-12-31 | $0.05B | $-0.01B | -14.29% |
| 2017-09-30 | $0.03B | $0.01B | 15.63% |
| 2017-06-30 | $0.02B | $-0.01B | -31.82% |
| 2017-03-31 | $0.02B | $0.00B | -15.00% |
| 2016-12-31 | $0.01B | $0.00B | -18.18% |
| 2016-09-30 | $0.04B | $0.00B | 7.69% |
| 2015-12-31 | $0.02B | $0.00B | -17.39% |
| 2015-03-31 | $0.00B | $-0.04B | -3700.00% |
| 2014-12-31 | $0.00B | $-0.04B | -4000.00% |
| 2014-03-31 | $0.00B | $-0.04B | -3500.00% |
| 2013-06-30 | $0.00B | $-0.03B | -3300.00% |
| 2011-06-30 | $0.00B | $-0.01B | 0.00% |
| 2011-03-31 | $0.00B | $-0.01B | 0.00% |
| 2010-12-31 | $0.00B | $-0.01B | 0.00% |
| 2010-06-30 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.002B | $0.034B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $169.446B | 31.11 |
| HCA Healthcare (HCA) | United States | $110.400B | 18.28 |
| CVS Health (CVS) | United States | $103.281B | 11.88 |
| Elevance Health (ELV) | United States | $84.880B | 12.45 |
| Cencora (COR) | United States | $68.936B | 22.22 |
| Natera (NTRA) | United States | $33.244B | 0.00 |
| DiDi Global (DIDIY) | China | $23.956B | 22.13 |
| Labcorp Holdings (LH) | United States | $22.291B | 17.00 |
| Medpace Holdings (MEDP) | United States | $17.409B | 43.22 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.189B | 0.00 |
| BioMerieux (BMXMF) | France | $14.802B | 0.00 |
| Viatris (VTRS) | United States | $14.789B | 5.51 |
| ICON (ICLR) | Ireland | $14.743B | 14.63 |
| Solventum (SOLV) | United States | $13.952B | 13.54 |
| Revvity (RVTY) | United States | $13.076B | 24.08 |
| CochLear (CHEOY) | Australia | $11.694B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.998B | 21.18 |
| Avantor (AVTR) | United States | $8.195B | 12.52 |
| Sonic Healthcare (SKHHY) | Australia | $7.725B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.652B | 0.00 |
| HealthEquity (HQY) | United States | $7.428B | 27.78 |
| BrightSpring Health Services (BTSG) | United States | $7.142B | 42.58 |
| Bausch + Lomb (BLCO) | Canada | $6.177B | 40.56 |
| PACS (PACS) | United States | $6.166B | 37.49 |
| Sotera Health (SHC) | United States | $5.497B | 26.51 |
| Alignment Healthcare (ALHC) | United States | $4.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.159B | 55.47 |
| Concentras Parent (CON) | United States | $2.766B | 17.26 |
| Organon (OGN) | United States | $2.262B | 2.38 |
| Progyny (PGNY) | United States | $2.096B | 41.20 |
| Surgery Partners (SGRY) | United States | $2.069B | 26.67 |
| Pediatrix Medical (MD) | United States | $1.947B | 11.63 |
| Establishment Labs Holdings (ESTA) | United States | $1.917B | 0.00 |
| Ardent Health (ARDT) | United States | $1.274B | 4.16 |
| Nutex Health (NUTX) | United States | $1.161B | 8.88 |
| Teladoc Health (TDOC) | United States | $1.159B | 0.00 |
| CareDx (CDNA) | United States | $1.058B | 17.29 |
| GoodRx Holdings (GDRX) | United States | $0.910B | 14.89 |
| Omada Health (OMDA) | United States | $0.906B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.794B | 0.00 |
| Embecta (EMBC) | United States | $0.746B | 4.24 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.702B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.599B | 0.00 |
| CryoPort (CYRX) | United States | $0.564B | 0.00 |
| Enhabit (EHAB) | United States | $0.551B | 24.75 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.495B | 0.00 |
| SBC Medicals (SBC) | United States | $0.463B | 8.51 |
| Agilon Health (AGL) | United States | $0.423B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.340B | 5.46 |
| Oncology Institute (TOI) | United States | $0.331B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.286B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.276B | 58.15 |
| So-Young (SY) | China | $0.267B | 0.00 |
| KindlyMD (NAKA) | United States | $0.213B | 0.00 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| LifeMD (LFMD) | United States | $0.181B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.136B | 0.00 |
| DocGo (DCGO) | United States | $0.088B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.28 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |